Route1 Announces First Quarter 2021 Financial Results Notification
ACCESSWIRE
05 May 2021, 23:19 GMT+10
TORONTO, ON / ACCESSWIRE / May 5, 2021 /Route1 Inc. (OTCQB:ROIUF)(TSXV:ROI) (the Company or Route1 ), an advanced North American provider of data-centric business empowerment solutions, today announced that it will report its financial results for the three-month period ended March 31, 2021 before the market opens on Thursday, May 20, 2021.
The Company will hold a conference call and web cast to provide a business update on Thursday, May 20, 2021 at 9:00 am eastern.
Participants should dial Toll-Free: 877-407-0782 or Toll/International: 201-689-8567 at least 10 minutes prior to the conference call and web cast. For those unable to attend the call, a replay will be available on May 20, 2021 after 4 pm eastern at Toll-Free 877-481-4010 or Toll/International 919-882-2331 passcode #41276 until 9 am on Thursday, June 3, 2021.
Cielo Announces Changes to the Board of Directors
ACCESSWIRE
VANCOUVER, BC / ACCESSWIRE / Cielo or the Company ) announces changes to its Board of Directors (the Board ). Robin Ray, Mel Angeltvedt and Lionel Robins have resigned from their Board positions, each for personal reasons. Mr. Ray is stepping down to devote more time on his accounting practice, Mr. Angeltvedt will focus his efforts on his own business opportunities and Mr. Robins intends to devote his time to his recent appointment as the COO with Cielo.
Cielo is also pleased to announce the appointment of Mr. Ryan Jackson to the Board. Mr. Jackson, a seasoned, experienced executive, has grown and developed several businesses and is currently the majority shareholder and managing director for RAMECO Group s portfolio of companies in consulting, commercial real estate, healthcare, leasing, finance, biotech and green technology. Mr. Jackson has led or taken part in numerous successful exits and is a Certified Manag
Innodata Announces New AI-Enabled Data Generation Offerings and Significant Win
ACCESSWIRE
05 May 2021, 23:05 GMT+10
NEW YORK, NY / ACCESSWIRE / May 5, 2021 / Innodata Inc. (NASDAQ:INOD), a leading data engineering company, today announced that it has expanded its AI data engineering capabilities to support synthetic data generation and has won its first significant new customer for synthetic data generation. Companies that are building artificial intelligence (AI) and machine learning (ML) models can utilize synthetic data when real-world data is insufficient or unavailable. For its latest win, Innodata successfully delivered a proof-of-concept for a synthetic data solution to one of the world s leading robotics process automation (RPA) companies that seeks to build and deploy high-performing, fast-to-scale AI algorithms to automate business processes.
Recruiter.com s Recruiter Index(R) to be Featured on CNBC for 12th Consecutive Month
ACCESSWIRE
HOUSTON
, TX / ACCESSWIRE / May 5, 2021 / Recruiter.com Group, Inc. (OTCQB:RCRT), an on-demand video hiring platform and hiring marketplace, is pleased to announce its Chairman and CEO, Evan Sohn, will present the results of the Company s Recruiter Index® for April 2021 live on CNBC this Thursday, May 6, on The Exchange, which airs 1 p.m. to 2 p.m. ET.
The Recruiter Index® is a survey of the Recruiter.com recruiter network, which is comprised of more than 27,750 small and independent recruiters. It has a successful track record of forecasting the Labor Department s jobs report by relying on the sentiment of recruiters.
NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter
ACCESSWIRE
First-Quarter 2021 Results and Highlights:
Consolidated revenue increased 9% to $116 million
Clinical Services revenue increased 4% to $96 million
Pharma Services revenue increased 46% to $19 million
Completed the acquisition of Trapelo Health in April
FORT MYERS, FL / ACCESSWIRE / May 5, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) (the
Company
), a leading provider of cancer-focused genetics testing services, today announced its first-quarter results for the period ended March 31, 2021.
Mark W. Mallon, the Company s CEO said I couldn t be more excited to be joining NeoGenomics at such a pivotal time in the Company s history. Trends in the business are strong and we are positioned well to take market share as we emerge from the pandemic. Today s announced acquisition of Inivata along with the completion of the acquisition of Trapelo Health in April are significant milestones on our journey t